Clinical Trial Update: A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and preliminary efficacy of DKN-01 in combination with lenalidomide and dexamethasone for relapsed or refractory multiple my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• DKN-01 (dkn-01)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Leap Therapeutics, Inc. | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED